US drug regulator heads for India to talk about quality
The top US drug regulator is headed to India, which supplies an estimated 40 percent of the generic drugs sold in the US, to talk about quality issues after recent action against some Indian drug makers. The US Food and Drug Administration announced Thursday that Commissioner Margaret A. Hamburg, will travel to India Feb 10-18 […]